The following pages link to Fast track (FDA)
External toolsShowing 50 items.
View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)- Controlled Substances Act (links | edit)
- Experimental cancer treatment (links | edit)
- Staphylococcus aureus (links | edit)
- Lyme disease (links | edit)
- Prescription drug (links | edit)
- Trastuzumab (links | edit)
- Trehalose (links | edit)
- New Drug Application (links | edit)
- Investigational New Drug (links | edit)
- Research exemption (links | edit)
- Spinocerebellar ataxia (links | edit)
- Geron Corporation (links | edit)
- Peanut allergy (links | edit)
- Comprehensive Drug Abuse Prevention and Control Act of 1970 (links | edit)
- Mitomycin C (links | edit)
- Asparaginase (links | edit)
- Amikacin (links | edit)
- Drug Price Competition and Patent Term Restoration Act (links | edit)
- Radioimmunotherapy (links | edit)
- Abbreviated New Drug Application (links | edit)
- Prescription Drug Marketing Act (links | edit)
- Deflazacort (links | edit)
- Public Health Security and Bioterrorism Preparedness and Response Act of 2002 (links | edit)
- Interleukin 15 (links | edit)
- Tolvaptan (links | edit)
- Nalmefene (links | edit)
- Center for Drug Evaluation and Research (links | edit)
- Lumiliximab (links | edit)
- Ocrelizumab (links | edit)
- Malaria vaccine (links | edit)
- Bedaquiline (links | edit)
- Research on Adverse Drug Events and Reports (links | edit)
- Triple-negative breast cancer (links | edit)
- Selective androgen receptor modulator (links | edit)
- Ceftobiprole (links | edit)
- FDA Fast Track (redirect page) (links | edit)
- Talizumab (links | edit)
- Delcath Systems (links | edit)
- Vocimagene amiretrorepvec/flucytosine (links | edit)
- Sanaria (links | edit)
- Zuranolone (links | edit)
- Donanemab (links | edit)
- Sulbactam/durlobactam (links | edit)
- Beremagene geperpavec (links | edit)
- Pozelimab (links | edit)
- Capivasertib (links | edit)
- Levacetylleucine (links | edit)
- Children in clinical research (links | edit)
- Enzalutamide (links | edit)
- Outline of clinical research (links | edit)
- Macular telangiectasia (links | edit)
- Enobosarm (links | edit)
- Pitolisant (links | edit)
- Apaziquone (links | edit)
- Iniparib (links | edit)
- CCR5 receptor antagonist (links | edit)
- Olaratumab (links | edit)
- BNC-210 (links | edit)
- Carfilzomib (links | edit)
- Givinostat (links | edit)
- Oncolytics Biotech (links | edit)